In the April Market Minute, our research analysts explain why they’re keeping a close eye on earnings reports, infrastructure spending, and money rolling into the equity markets in April.
For March 2021, our Research Analysts are keeping an eye on the recently passed stimulus, rising interest rates, and the turning tides from growth to value stocks. This article is for demonstrative and academic purposes and is meant to provide valuable background information on particular investments, NOT a recommendation to buy. The investments referenced within…
The “Money Talks” Experts discuss our current economic cycle, fears of inflation and the mixed inflationary signs, and the need for additional stimulus.
For the month of February, the Henssler Research Analysts are keeping an eye on positioning, economic momentum, and inflation.
In this special Inauguration edition of the Market Minute, the Henssler Research Analysts are watching for additional stimulus, a tax plan, and regulation of Big Tech now that the Biden Administration is in control.
We can honestly say we never expected to see anything like we did on Jan. 6, 2021 in this country. Watching the appalling display at the Capitol leads to fear and anger. It can even lead to a feeling of helplessness.
The Henssler Research Analysts discuss how the market ended 2020 and what they expect for 2021. They discuss sector performance, the difference between growth and value stocks, and inflation.
In the month of December, the Henssler Financial Research Analysts are closely watching the COVID Relief coming out of Washington, Consumer Confidence, and Inflation and how it will affect the Fed’s benchmark interest rates. This article is for demonstrative and academic purposes and is meant to provide valuable background information on particular investments, NOT a…
In our latest Fear Vs. Finance video, we look at how the Space Race and the Cuban Missile Crisis affected the market both short- and long-term.
For the month of November, the Henssler Research analysts are monitoring the developing COVID-19 vaccine, the contended Senate runoff elections, and the stock valuations in the market.
